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A B S T R A C T
The objective of the present work is to demonstrate a rational way to prepare selective sorbents able to extract
simultaneously several structural analogs. For this purpose the binding specificity of two hexapeptides com-
putationally designed (VYWLVW and YYIGGF) versus four synthetic cannabinoids Naphthalen-1-yl-(1-pentylin-
dol-3-yl)methanone (JWH 018), naphthalen-1-yl-(1-butylindol-3-yl)methanone (JWH 073),
(R)-(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM 1220) and
(R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenyl-
methanone (WIN 55) was computationally studied and then experimentally tested by solid-phase extraction
(SPE) clean-up and ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS)
analysis. The two peptides were chosen using a semi combinatorial virtual technique by generating 4 cycles of
peptide libraries (around 2.3×10⁠4 elements). To select the two peptides, the simulated binding scores between
synthetic cannabinoids and peptides was used by maximizing the recognition properties of amino acid motif be-
tween the two JWH and the other synthetic cannabinoids. In particular, the peptide YYIGGF, having also affinity
for AM 120, was selected as control because it was the only one without tryptophan residues within the best pep-
tides obtained from simulation. Experimentally, the two hexapeptides were tested as SPE sorbent using nanomo-
lar solutions of the four drugs. After optimization of best retentions the binding constants were calculated by
loading synthetic cannabinoids solutions at different concentrations. The results indicated a strong interac-
tion between hexapeptide VYWLVW and JWH 018 (15.58±2.03×10⁠6 M⁠–1), 3-fold and 40-fold larger com-
pared to the analog JWH 073 and both AM 1220 and the WIN 55. Similar trend was observed for the
hexapeptide YYIGGF but the binding constants were at least three times lower highlighting the key role of
the tryptophan. To demonstrate the hexapeptides specific interaction with only synthetic cannabinoids, a
cross-reactivity study was carried out using other drugs (cocaine, morphine, phencyclidine and metham-
phetamine) in the same SPE condition. Finally the practical utility of these peptide modified sorbent ma-
terials was further demonstrated by detecting the synthetic cannabinoids in real samples using hair ma-
trix.
1. Introduction
In the last years new synthetic cannabinoids were extensively stud-
ied in forensic science [1–5]. The importance of this type of drugs
is well described by different works reporting that these new sub-
stances with cannabis-like effects are more and more frequently ob-
served in the drug scene [6–9]. A fast and cheap detection of drugs
of abuse can be carried out with immunochemical methods but, re-
grettably, those methods are unsuitable for a systematic toxicologi-
cal analysis requested by these new molecules that continuously ap
pear on the illicit market [10,11]. To have a determination of psychoac-
tive substances and their metabolites with high mass accuracy, liquid
chromatography can be coupled with high resolution mass spectrome-
try (MS) [12,13]. In modern illicit drug testing sample clean-up takes
50–75% of the total analysis time and remains one of the main bot-
tlenecks [14]. Generally, to detect synthetic cannabinoids, commercial
resins without any post functionalization are used to clean up samples
like wastewater, human serum, whole blood, urine and hair [12,15–17].
Recently, new molecular recognition sorbents were proposed in SPE as
aptamers, peptides and molecular imprinted polymers (MIPs) [18–21].
These new affinity media used in selective extraction, have similar
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performances of antibodies by overcoming several drawbacks as cost,
variability in binding properties between lot-to-lot and chemical degra-
dation [22,23]. Usually DNA aptamers and peptides are selected via
combinatorial chemistry subjected to complex laboratory procedures
that increase exponentially with the number of executed cycles [24,25].
The introduction of predictive computational models, instead of trial
and error procedures, offers advantages in minimizing experimental
problems like non-specific recognition, reagent stability and costs.
In the past years molecular modelling was used to rationally design
synthetic receptors mostly in MIPs selection but only few times for pep-
tides [26–29]. In this work we investigated the thermodynamic binding
properties versus synthetic cannabinoids of hexapeptides used as sta-
tionary phase in SPE. The peptides were chosen after a virtual screen-
ing by applying a semi combinatorial strategy driven by maximizing
the difference in binding within the synthetic cannabinoids studied. The
peptides were tested as sorbent materials for retaining 4 different syn-
thetic cannabinoids and the selectivity was proofed using other common
drugs. Finally, the practical applicability of these sorbent materials func-
tionalized with peptides were tested in real samples using hair matrix.
This paper confirms that good results could be achieved without the use
of only empirical methods such as combinatorial screening that require
difficult and expensive procedures in terms of time and resources.
2. Materials and methods
2.1. Virtual screening
In a preliminary step, the zwitterionic form of all the considered
peptides was generated using Hyperchem 8.0.5 software on a Microsoft
Windows 7 laptop. All the other modelling steps were performed using
Openeye Scientific Software tools (www.eyesopen.com) with free acad-
emic license. All molecular modelling experiments were performed on
a in desktop 19 processors Intel Xeon X5690 at 3.47 GHz each, with
94.5 GiB RAM, running Kernel Linux 2.6.32-642.1.1el6.x86_64, GNOME
2.28.2. The main computational procedure can be resumed in the fol-
lowing steps:
1. Drawing ligands via LEXICHEM 2.1.0 package, by converting ligands
standard IUPAC names into their corresponding structures [30].
2. Minimizing and optimizing molecular geometries of peptide libraries
and ligands by means of SZYBKI 1.5.7 with default parameterization
[31].
3. Creating conformers by exploring with OMEGA 2.4.6 the conforma-
tional space for both receptors and ligands [32–34].
4. Creating the binding box and docking peptide libraries to the syn-
thetic cannabinoids using multi-conformer rigid body docking pro-
gram OEDocking 3.0.0, also with default parameters [35].
For the molecular docking step, the peptides as a whole were consid-
ered as receptors, meaning that for each peptide conformer, the entire
molecular surface was included in the active site box defining the area
where ligands were expected to bind. The scoring function used in this
step was Chemgauss4, a modification of Chemgauss3, with improved
hydrogen bonding and metal chelator terms. The time elapsed for pro-
cessing each peptide conformer was about 2 min per processor, covering
the generation of initial 3D structures to final docking results. In the fi-
nal step, the binding score average for each peptide was calculated over
all the conformers. In the simulations, ten conformers per peptide and
a maximum of 200 conformers for each of the four ligands were con-
sidered. This ensures a good compromise between calculation time and
accuracy of the output data for this type of receptors [36]. In the dock-
ing process, a dedicated box (500–7500 Å⁠3) was generated for each re-
ceptor vs. the 4 synthetic cannabinoids used as ligands. The lower score
values, calculated using Chemgauss4 scoring function, represented the
higher ligand-receptor affinity.
For visualizing structures, generation of molecular surfaces and
analysis of physicochemical properties it was used VIDA 4.2.1 [37].
The net charge of peptides at pH 7, and their isoelectric points were
calculated by using an on
line tool for calculating peptide properties (http://www.innovagen.se/
custom-peptide-synthesis/peptide-property-calculator.asp). The entire
process was automated using a bash script and for post processing data
analysis using a freeware BASIC-like scripting language (AutoIT V3) on
a Microsoft Windows 7 laptop.
2.2. Experimental testing
2.2.1. Reagents
The standards of synthetic cannabinoids JWH 018, JWH 073, AM
1220 and WIN 55 were purchased from Cayman Chemical (Ann Arbor,
MI, USA) at a concentration of 1 or 0.1 mg mL⁠−1 based on availabil-
ity. Standards of cocaine (COC), phencyclidine (PCP), morphine (MOR)
and methamphetamine (MAMP) were purchased from LGC Standard
(Italy). The purity of the reference compounds was >99%. All stan-
dards were provided at a concentration of 3 mM. Individual stock solu-
tions were prepared in methanol at 300 μM and working standard mix-
tures were prepared by appropriate dilution of the standard solutions
in methanol. All solutions were stored at −20 °C in dark condition. All
buffer reagents, methanol, acetonitrile and water were acquired from
Fisher Scientific (Fair Lawn, NJ, USA). All solvents employed in the ex-
traction were ultra-performance liquid chromatography (UPLC) grade,
and LC–MS grade in the chromatographic system.
The solid phase extraction sorbent materials VYWLVW-resin (W) and
YYIGGF-resin (F), with a peptide substitution level of 0.17 mmol g⁠−1
and a synthesis reproducibility >95%. were bought from EspiKem srl
(Italy). The resin used to attach the hexapeptides was a Fmoc-PAL-AM.
The C-18 cartridges (30 mg mL⁠−1) were from Phenomenex. SPE Isolute
column (Empty 1 mL Reservoir) was from STEPBIO (Italy).
2.2.2. Solid phase extraction
The cartridges (volume 1 mL) were packed with 30 mg of resin (the
blank) or modified hexapeptide resin dissolved in 5 mL of a methanol/
water solution (80:20, v/v) and kept at room temperature for 6–8 h.
This suspension was slowly loaded into the cartridge with a teflon frit
on the bottom. During this procedure, the cartridge was continuously
shaken in order to obtain a homogeneous packing. After loading, a sec-
ond frit was used to cover the resin into the cartridge. Then the car-
tridge was conditioned and equilibrated by washing with methanol. All
the experiments were carried out by means of a VISIPREP device and
the solvent fractions collected were named progressively. The extraction
procedure was performed in four steps:
1. Conditioning of the stationary phase with methanol/water solution
(20:80, v/v).
2. Sample loading (1 mL).
3. Washing with 1 mL of phase with methanol/water solution (20:80,
v/v).
4. Elution with 1 mL of methanol.
The same extraction procedure was applied to cartridges packed
with the resin without hexapeptides (the blank) and the C-18 cartridge.
2.2.3. UHPLC-MS/MS analysis
The procedure was optimized and validated in a previous work [12].
Briefly, chromatographic separation was achieved with a Beta-Basic 18
column, 150×2.1 mm (Thermo Scientific, Bremen, Germany) held at a
temperature of 40 °C and a flow rate of 0.6 mL min⁠−1. Mobile phases
were 0.1% formic acid in water (Phase A) and 0.1% formic acid in ace-
tonitrile (Phase B). The gradient elution was as follows: the initial com-
position (5% B) was increased from 5% to 50% B over 4.5 min, from
50% to 100% over 0.5 min, held at 100% for 2 min and returned to ini-
tial conditions over 1 min. A 2 min equilibration followed, yielding a
total run time of 10 min.
The UHPLC equipment consisted of a Nexera LC20AD XR system,
with autosampler, vacuum degasser and column oven, from Shimadzu
(Tokyo, JA) coupled with a 4500 Qtrap from Sciex (Toronto, ON,
Canada) equipped with
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a Turbo V electrospray ionization (ESI) source was used for multi-class
drug analysis.
The analytes were detected in positive ionization (PI) with a capil-
lary voltage of 5500 V, nebulizer gas (air) at 60 psi, turbo gas (nitrogen)
at 50 psi at a temperature of 600 °C.
Two multi-reaction monitoring (MRM) transitions were chosen for
each analyte. The ion currents were acquired in MRM mode and quanti-
tation was performed by the IS method using Multiquant Software from
Sciex. The selected MRM transitions and UHPLC–MS/MS parameters are
reported in Table 1.
2.2.4. Hair extraction
For external decontamination cut hair was washed with water and
twice methanol by vortex mixing for 2 min. Hair samples were forti-
fied by soaking using a previously reported procedure [38]. Briefly, hair
were cut and immersed in a flask containing a solution consisting of
1.5 mL of HCl (0.02 M in dimethyl sulfoxide (DMSO)) and 1.5 mL of
water containing the analytes. The hair samples were then soaked for
21 days, filtered using a Büchner funnel and washed with water and
methanol.
After removal of solvent, hair was air-dried and further cut into
1–2 mm segments. The sample was homogenized with diatomaceous
earth (Sigma-Aldrich, Milan, Italy) using a mortar and pestle. The mix-
ture was then placed in a 1 mL pressure resistant stainless steel cell
that was sealed at both ends with cellulose filters. Void volumes in the
cell were filled up with diatomaceous earth and 25 μL of an internal
standard were added at a concentration of 50 nM in methanol. Hair in-
cubation was performed by pressurized liquid extraction (PLE) using
a Dionex ASE 200 (Sunnyvale, CA, USA) accelerated-solvent-extraction
system. A single extraction cycle was performed using as extraction sol-
vent a 70:30 (v/v) water–methanol mixture. The extraction conditions
were as follows: pressure 100 bar; temperature 120 °C; preheat time
1 min; heat time 7 min; static time 5 min; flush volume 0%; purge time
60 s. The PLE extract (5–6 mL) was automatically collected in glass vial
with caps solvent resistant (PTFE) septa. PLE extracts were transferred
into a conical tube and centrifuged at 6000×g for 5 min at 25 °C.
3. Results and discussion
3.1. Virtual screening
An incremental construction approach was used by taking in every
subsequent iteration, a focused library of peptides of increasing com-
plexity, built on previous iteration results. The virtual screening proce-
dure is resumed in Fig. 1. The approach aimed for higher ligand affini-
ties by improving both the flexibility and chemical complementarity of
peptides. In practical terms the simulated binding scores between syn-
thetic cannabinoids and peptides was used to select in each screening
stage 50 of the top average scoring peptides, 25 vs both JWH and 25
for the other two synthetic cannabinoids. These peptides had relevant
aminoacid composition and structural features that allowed them to ef-
ficiently bind the ligands. In order to refine and improve their affinity
for the ligands, these peptides were used as seeds for generating new
combinatorial libraries by inserting each of the 20 natural aminoacids
in every position of the sequence.
With this approach nearly 2.3×10⁠4 peptides were screened during
the entire computational phase. However, this is a very small number
compared to a full scale combinatorial screening of all 6.4×10⁠7 possi-
ble hexapeptides. Actually, with the strategy used, it was possible to
identify good receptors for the ligands analyzed by exploring a mini-
mum fraction (0.01% approximately) of the entire hexapeptides sample
space. As shown in Table 2, each screening stage successfully narrowed
the minimum – maximum binding scores variability, as well as the av-
erage binding scores, indicating that the peptides complexity increased
together with their affinity for the ligands. It should be noted that posi-
tive binding scores indicated a virtually no positive interaction between
ligand and receptor molecules, thus, association complexes were not fa-
vorable. The statistical behavior of peptides libraries confirms a symme-
try in the distribution with average and median very similar in all cases.
These results highlighted a steady and significant trend to improve
binding scores in each following stage. Libraries were more focused
after each iteration, so it was possible to find better receptors for
the ligands studied. The average scores toward the fourth and final
stage show a tendency to stabilize, indicating that further iterations
of the process may not give significant improvement over the results
obtained at that point. For example, the difference
Table 1
The selected MRM transitions and UHPLC–MS/MS parameters used for the 4 synthetic cannabinoids.
Analyte t⁠R Q1 DP EP Q3 CE CXP
(min) (amu) (V) (V) (amu) (V) (V)
JWH 018 3.25 341.90 37.00 12.00 155.00 34.00 6.00
126.90 69.00 20.00
JWH 073 2.85 328.00 41.00 12.00 155.00 33.00 8.00
126.90 62.50 22.00
WIN 55 2.25 426.90 45.00 10.00 154.90 40.00 25.00
98.80 67.00 13.00
AM 1220 1.54 382.90 35.00 12.00 98.00 54.60 47.00
112.00 35.00 33.00
Fig. 1. The 4 steps virtual screening procedure. In the first three stages, starting with a library of 8000 tripeptides, peptides complexity was selectively increased in successive stages until
reaching the hexapeptide length. The fourth and final stage aimed to identify the synthesis candidates. An approximate grand total of 23k peptides were screened in the entire process.
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Table 2
Statistical parameters of the scores behavior obtained using 4 peptides libraries versus the
4 synthetic cannabinoids.
JWH 018 JWH 073 AM 1220 WIN 55
Tripeptides
Min −0.51 −0.55 −1.20 0.46
Max 5.93 5.35 5.63 7.74
Av 3.22 2.70 2.74 4.63
Median 3.31 2.77 2.82 4.67
Tetrapeptides
Min −1.31 −1.35 −1.33 0.16
Max 4.73 4.35 4.13 7.34
Av 2.01 1.70 1.34 3.35
Median 2.16 1.78 1.30 3.35
Pentapeptides
Min −1.92 −2.02 −2.27 −0.77
Max 2.65 2.55 2.62 3.54
Av 0.65 0.35 0.24 1.90
Median 0.6 0.36 0.15 1.79
Hexapeptides
Min −2.54 −2.76 −2.95 −1.39
Max 2.18 1.89 1.84 2.89
Av −0.10 −0.35 −0.42 1.14
Median 0.01 −0.30 −0.37 1.16
of binding score averages between first and second stages, and second
to third is approximately 1.27 units, while third to fourth iteration av-
erage binding score difference is just 0.72 units.
The weakest interactions were found with WIN 55, probably because
of its size and high polarity when compared to the other ligands. Lig-
ands AM 1220 and JWH 073 yielded similar results and slightly better
affinities than JWH 018, in general all three had the best association
complexes.
Table 3
The 20 hexapeptides with best binding score averages vs. JWH 018.
JWH 018 JWH 073 AM 1220 WIN 55
TEAWWF −2.54 −1.68 −1.04 −0.67
WWFYAF −2.52 −2.75 −1.85 −0.51
VYWLVW −2.47 −2.28 −0.25 0.04
WCNWFV −2.46 −2.02 −2.04 0.15
KWWADF −2.44 −2.12 −1.18 0.41
EWWAFM −2.4 −1.90 −1.75 −1.01
EAAWWF −2.37 −2.65 −1.23 −0.34
WWFAHF −2.37 −2.28 −2.67 −1.19
CWWCWA −2.32 −2.74 −2.73 −1.07
WWFAFL −2.3 −2.74 −2.09 −1.34
WAHEWF −2.29 −2.54 −1.96 −0.64
EAWQWF −2.29 −2.21 −2.28 −0.94
AEAWWH −2.26 −2.46 −1.45 −1.08
AEFWWH −2.22 −2.5 −0.88 −0.31
IWWFAF −2.2 −2.52 −1.05 −0.13
ELAWWF −2.2 −2.27 −1.05 −0.11
MWHCFL −2.19 −1.90 −2.47 0.12
YYIGGF −2.18 −2.23 −2.07 −0.05
EAGWWH −2.17 −2.49 −1.00 −1.01
VEAWWF −2.15 −2.35 −1.01 −0.16
Once the final screening stage was completed, top scoring hexapep-
tides were evaluated. This results analysis was finalized to maximize the
recognition properties of amino acid motif between the two JWH and
the other two synthetic cannabinoids. The underlying idea was to find
peptides with different affinities for the drugs studied, so that when they
are used as sorbent materials, they could retain selectively functional
analogs from the others drugs. In Table 3 an example of the average
binding scores vs. the four synthetic cannabinoids obtained for the 20
top scoring hexapeptides vs JWH 018. The data analysis showed that top
peptides had the same behavior in binding both JWH with also strong
interaction with AM 1220 but less for WIN 55. The presence of aromatic
residues in top peptides were relevant for an effective receptor-ligand
association. Particularly, tryptophan was present in almost all the top
hexapeptides vs JWH. Also, phenylalanine residue was well represented
among the top ranked peptides.
In order to have in experimental trials a selective recognition be-
tween the synthetic cannabinoids, two peptides VYWLVW and YYIGGF
were chosen, the first able to differentiate both JWH from the rest and
the later with a good interaction also for AM 1220. Moreover the pep-
tide YYIGGF was chosen as control to study the interaction of pep-
tide-synthetic drugs without tryptophan. In fact, this peptide was the
only one without tryptophan residues within the top peptides vs JWH
018.
In Table 4 are presented some structural and physicochemical para-
meters calculated for each structure, both ligands and receptors. Pep-
tide YYIGGF was significantly more polar than VYWLVW, because of the
relatively high content of tyrosine and absence of tryptophan. Glycine
residues could also contribute since they are small and their backbone
has lower steric hindrance thus, is more exposed.
Regarding the ligands, the parameters calculated for JWH 018 and
JWH 073 were similar since the only difference between them is a
methyl group. They are hydrophobic molecules with few possibilities of
forming H-bonds. However, WIN 55 is, in comparison, very polar and
with higher propensity to form H-bonds. The differences observed are
in agreement with simulations and suggest that both JWH ligands can
form better association complexes with peptide VYWLVW, whereas pep-
tide YYIGGF can also bind AM 1220. Both peptides had very weak inter-
action with WIN 55 because of strong polar surface area, therefore this
ligand was used as control in experimental part.
The Interaction zones and type of contacts are shown in Fig. 2. The
receptor-ligand interface in the association complexes were very similar
in each peptide. Peptide VYWLVW formed an aromatic rich convex in-
teraction surface with residues 2, 3 and 6. Ligands displayed a tendency
to bury the indole system inside that hull, with nitrogen pointing to its
bottom. On the other hand, the interaction zone of YYIGGF acquired a
saddle-like configuration where almost all residues had a direct contri-
bution except for isoleucine in position 3 which was facing outwards.
Both cavities were highly hydrophobic, however, in YYIGGF the peptide
backbone was closer to the surface granting a slight polar character to it.
This would explain why AM 1220 and WIN 55 had better binding scores
with this peptide than with VYWLVW. It is also important to note that
the interaction zone of both hexapeptides with WIN 55 was displaced
with respect to the other three ligands.
Table 4
Calculated structural and physicochemical parameters of molecules selected in the experimental part. N confs=number of conformers; MW=molecular weight; PSA=polar surface area;
RB=rotatable bond; Acc=Lipinski acceptors; Don=Lipinski donors.
Net charge Iso point MW LogP PSA RB Acc Don
Peptide pH 7 (pH)
F: YYIGGF 1 9.59 719 0.44 253 76 15 8
W: VYWLVW 1 9.84 865 4.02 265 101 16 9
Compound Chemical formula N Conf MW LogP PSA RB Acc Don
JWH 018 C24H23NO 200 341 6.54 22 46 2 0
JWH 073 C23H21NO 200 327 6.04 22 44 2 0
AM 1220 C26H27N2O 200 384 5.7 26 56 3 1
WIN 55 C27H27N2O3 85 428 3.49 44 60 5 1
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Fig. 2. Three-dimensional structures of the two hexapeptides and the 4 synthetic cannabinoids used in this work, as well as the best association complexes formed between them.
3.2. Experimental testing
The SPE protocol included conditioning, sample loading, washing,
and analyte elution steps. In a first pilot test the volume ratio of
methanol/water solution was studied. In both washing and condition
steps, three different volume ratio of respectively 10:90, 20:80 and
30:70 were tested. For all the four synthetic cannabinoids loaded at the
100 nM an increase in retention was observed using methanol/water so-
lution 20:80 v/v; when the methanol was over 30% a drastic decrease
in retention was obtained for all the four drugs. These data drove to
use methanol as elution solvent. In fact, after washing the cartridges
with methanol all molecules were eluted and, in terms of reusability
all experimental trials (more than 100 tests) could be carried out us-
ing the same cartridge for the duration of one month without any loose
of performance. To evaluate no-specific interactions between drugs and
resin, a cartridge was packed with the stationary phases without hexa-
peptides (blank) showing no significant retentions for all the four drugs
(less than 10%) at the optimized SPE conditions (methanol/water solu-
tion 20:80 v/v). It should be noted that before their application, the car-
tridges were swelled and dried several times because higher retention
was observed after 10 cycles of conditioning and washing.
After this preliminary optimization, the pH effect on the hexapep-
tides retention was studied. The AM 1220 and WIN 55 can be slightly
deprotonated by changing the pH and the hexapeptides were attached
to the resin via the carboxyl-terminus leaving free to deprotonate the
N-terminus group. Three buffer solutions, formate buffer (pH 3.5), phos-
phate buffer (pH 7.0) and ammonia buffer (pH 8.5) were prepared for
loading the drugs. Drugs were loaded at different pH at 100 nM, the
cartridges were then washed with 1 mL of methanol/water solution
20:80 v/v and the analyte was eluted using 1 mL of methanol.
Table 5 shows the SPE experimental results using the two hexapep-
tides as sorbent retaining 100 nM solutions of the four drugs at pH 3.5,
7.0 and 8.5. At pH 7.0 the results reflected those obtained in prelimi-
nary tests, with the highest retention (85%) showed by VYWLVW-resin
for JWH 018 and a clear difference in retention between the two JWH
and the other synthetic cannabinoids (AM 1220 and WIN 55). This be-
havior was predicted by the simulation for the hexapeptide VYWLVW
but not for the hexapeptide YYIGGF that showed a significant simulated
binding for the AM 1220. The two JWH, having a similar molecular
structure, were retained by both hexapeptides in similar manner hav-
ing a decrease in retention using ammonia buffer at pH 8.5 and no sig-
nificant change in retention for pH 3.5. Only the YYIGGF-resin had a
Table 5
SPE experimental results using the selected hexapeptides as sorbent versus 100 nM solu-
tions of the four drugs at pH 3.5, 7.0 and 8.5. F: YYIGGF; W: VYWLVW. The results were
expressed as percentage in retention.
pH 3.5 pH 7 pH 8.5
(%) (%) (%)
JWH 018 F 59±3 72±3 45±2
W 83±7 85±5 73±6
JWH 073 F 50±3 69±6 48±4
W 76±7 78±5 76±6
AM 1220 F 30±2 51±3 41±4
W 35±2 55±4 50±3
WIN 55 F 45±4 54±5 44±4
W 52±4 62±3 61±6
loss in retention particularly for JWH 073. A low retention was observed
while using both AM 1220 and WIN 55 having a molecular structure
rather different than the two JWH. Particularly AM 1220 at low pH pre-
sented the lowest retention for both hexapeptide sorbent materials (W
and F).
The best retention condition for all synthetic cannabinoids was at pH
7.0 and this pH was used for calculating the binding constants of the
hexapeptides-synthetic cannabinoids complexes. The binding constants
were calculated by loading synthetic cannabinoids solutions at differ-
ent concentrations ranging from 3.0×10⁠−8 to 3.0×10⁠−5 M. A saturation
effect was observed at micromolar concentration. After subtracting the
unspecific bound contribution given by blank cartridge retention, the
bound drug was determined by subtracting the free analyte from the
total loaded. Considering 1:1 complexation stoichiometry, the ratio be-
tween bound and free drug versus the bound one was plotted and the
binding constant was calculated by fitting a linear regression through
these data [39].
The results, reported in Table 6, indicated a strong interaction be-
tween hexapeptide VYWLVW and JWH 018 that was around 3-fold and
40-fold larger compared to the analog JWH 073 and both AM 1220 and
the WIN 55. Similar trend was observed for the hexapeptide YYIGGF
but the binding constants for the two JWH were at least three times
lower. This behavior was predicted in simulation for the hexapeptide
VYWLVW highlighting the key role of tryptophan in binding JWH,
but not for hexapeptide YYIGGF showing, in these experimental condi-
tions, no selectivity in binding also AM 1220. One of the factor influ-
encing peptide-drug binding constant was the solvent effect. In experi-
mental assay carried out in 20% of methanol, the solvent interference
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Table 6
Assessment between the virtual binding scores and the experimentally binding constants
of hexapeptide-drug complexes, all calculated at pH 7.0. Binding score in percentage was
calculated using the entire hexapeptides library results having the top and bottom score
values respectively of −2.95 and 2.89.
Experimental K binding ×10⁠6
(M⁠–1)
Virtual binding score
%
F W F W
JWH
018
2.27±0.30 15.58±2.03 87 92
JWH
073
0.98±0.13 5.84±0.41 88 89
AM
1220
0.18±0.01 0.37±0.05 85 54
WIN 55 0.21±0.02 0.41±0.04 50 49
was relevant and receptor-ligand interactions could be more hindered
for AM 1220 and the WIN 55 than for the two JWH, resulting in much
lower affinity. In fact both AM 1220 and WIN 55 are richer in hydrogen
donor/acceptor centers than the JWH counterparts.
The molecular docking functions used in this work ignored sol-
vent-related terms (i.e., hydrogen bonding interactions with implicit sol-
vent). The rigid body docking approach attempted to simplify the ex-
perimental conditions in order to process large amount of data in rea-
sonable time. Considering this, it is well known that simulated and ex-
perimental results not necessarily always match. In this case, molecular
docking provided the prediction of grossly wrong electrostatic proper-
ties thus allowing for careful experimental assays on a relatively small
number of database compounds.
The binding properties of peptide sorbent materials were compared
to the blank and C-18 SPE cartridges using the same extraction proto-
col. Moreover to demonstrate that in these SPE conditions the observed
retention response by the hexapeptides had specific interaction with
only synthetic cannabinoids and not with other drugs, we compared the
specificity of the hexapeptide sorbent materials using 100 nM of other
common drugs. For this purpose, cocaine, morphine, PCP and MAMP
were chosen to study the cross-reactivity of the hexapeptides. Fig. 3A
illustrates the selectivity of the hexapeptide sorbent materials (W and
F), the blank and the C18 vs the four synthetic drugs. The Fig. 3B de-
picted the cross-reactivity performances of those cartridges in retaining
the other drugs (cocaine, morphine, PCP and MAMP).
As expected, the C-18 resin having a wide interaction range showed
a similar response for the four synthetic cannabinoids and the other
drugs. The blank in all cases had a poor retention demonstrating no in-
terference in studying the peptides binding. The response in retention
of the peptides cartridges, obtained under the same experimental con-
ditions and using the same drugs concentration (100 nM) demonstrated
clearly that both peptides resins retained only the synthetic cannabi-
noids with at the least six fold less retention for the other drugs. These
results are consistent with previous and confirm the possibility to use
these peptides as selective sorbent materials for JWH synthetic cannabi-
noids.
The practical utility of these modified sorbent materials was further
demonstrated by detecting the synthetic cannabinoids in real samples
using hair matrix. Hair matrix is often used in forensic laboratories be-
cause it offers wider time window, non-invasive sampling and good sta-
bility of the analytes over time. Moreover, On the basis of literature
data, hair sample is quite more challenging than urine in terms of com-
plexity, especially in synthetic cannabinoids detection [12,40–42].
Hair extraction procedure involved a preliminary washing step, hair
incubation by pressure PLE followed by SPE clean-up. All steps were
optimized in a previous work to obtain best recoveries and low ma-
trix effect [12]. The hair samples were fortified by soaking that is
considered a good alternative for drug users’ hair in analytical pur-
poses [43]. In the present study, the first experiments were focused
on an optimization of extraction solvent using two different buffer/
methanol 80/20 v/v mixtures one more acidic using acetate and the
other with phosphate at pH 7.0. In acidic condition poor recovery was
Fig. 3. Selectivity (A) and cross-reactivity tests (B) using the resins W, F, blank and C-18
versus: A) the 4 synthetic cannabinoids; B) Morphine (MOR), Methamphetamine (MAMP),
cocaine (COC) and Phencyclidine (PCP). All drugs at the concentration of 100 nM. The
drugs recovery was reported in percentage.
obtained, but it was observed an increase of drugs elution with using
phosphate buffer thus a better SPE recovery.
Tests were carried out using 50 mg of hair sample fortified with
a mix of the four synthetic cannabinoids each at 100 nM. After PLE
procedure, the extracts were processed with the SPE parameters previ-
ously optimized, using VYWLVW-resin (W) and C-18 cartridges. As il-
lustrated in Fig. 4 the W resin had a good retention of both JWH de-
creasing for the other two synthetic cannabinoids as also reported by
the data obtained in standard solutions. The C-18 resin gave an oppo-
site response in retention the synthetic cannabinoids with poor recovery
for both JWH and more than 80% for AM 1220 and WIN 55. Such be-
havior should be explained by steric effects more than by hydrophobic
properties. In fact, the JWH logP, the hydrophobic parameter reported
in Table 4, was higher than the one calculated for the other two syn-
thetic cannabinoids.
The selectivity performances of resin W towards C-18 sorbent was
proved by the evaluation of matrix effect: in hair matrix usually sig-
nificant matrix effect often occurs with a strong suppression of ion
signal in ESI; the extracts
Fig. 4. Hair matrix analysis. The recovery of resin W and C-18 vs the 4 synthetic cannabi-
noids was reported in percentage.
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that have been submitted to clean-up showed very low ion suppression
for both JWH (<5%), 10% for WIN 55% and 18% for AM 1220. The
ion suppression for the same analytes recorded using C18 cartridges was
quite higher (>30% for all analytes).
Despite the difference between standards and real samples, the use
of hair samples confirmed a good selectivity within the four synthetic
cannabinoids studied and this can be useful when selective separation is
necessary.
4. Conclusions
Avoiding very large procedures like combinatorial work, we ob-
tained a focused peptides with high affinity properties vs the two JWH
synthetic cannabinoids. The approach was based on the concept that
recognition properties of amino acid motif can be increased by an incre-
mental construction approach by taking in every subsequent iteration, a
focused library of more complex peptides showing greater binding prop-
erties. The work can be repeated for as long as necessary to identify a
ligand with sufficient affinity.
Binding constants calculated in experimental step confirmed the pur-
pose to have a selective response between synthetic cannabinoids, sup-
porting the semi combinatorial virtual procedure that was carried out
maximizing the differences of the peptides affinity vs the synthetic
cannabinoids. This fact was also confirmed in SPE by the two hexa-
peptides having specific interaction with only JWH synthetic cannabi-
noids and not with other drugs (cocaine, morphine, phencyclidine and
methamphetamine). Moreover the hexapeptide sorbent materials
showed completely differ retention with drugs compared with a com-
mercial C-18 cartridge. These differences were also highlighted using
hair matrix showing the practical applicability of these kind of pre ana-
lytical selective clean up tools in real samples analysis.
However, the experimental results confirmed only in part the fea-
sibility of virtual screening to produce peptides with selective proper-
ties. In fact using the virtual designed peptides YYIGGF it was not pos-
sible to have a good experimental binding affinity for AM 1220 as pre-
dicted in virtual screening. In this case simulation and experiments did
not match probably because the molecular docking functions used in
this work ignored solvent-related terms (i.e., hydrogen bonding interac-
tions with implicit solvent). In both virtual and experimental data the
weakest interactions were found with WIN 55. This was due to its size
and high polarity when compared to the other ligands. For those kind
of compounds other dedicated virtual procedure has to be carried out.
This methodology can be extended to other new drugs that are more
and more frequently observed in the illicit market.
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